Opioids Inhibit Lateral Amygdala Pyramidal Neurons by Enhancing A Dendritic Potassium Current by Faber, E. S. L. & Sah, P.
Cellular/Molecular
Opioids Inhibit Lateral Amygdala Pyramidal Neurons by
Enhancing a Dendritic Potassium Current
E. S. Louise Faber1,2 and Pankaj Sah1,2
1Division of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia, and 2The Queensland
Brain Institute, University of Queensland, Brisbane QLD 4072, Australia
Pyramidal neurons in the lateral amygdala discharge trains of action potentials that show marked spike frequency adaptation, which is
primarily mediated by activation of a slow calcium-activated potassium current. We show here that these neurons also express an
-dendrotoxin- and tityustoxin-K-sensitive voltage-dependent potassium current that plays a key role in the control of spike discharge
frequency. This current is selectively targeted to the primary apical dendrite of these neurons. Activation of -opioid receptors by
application of morphine or D-Ala 2-N-Me-Phe 4-Glycol 5-enkephalin (DAMGO) potentiates spike frequency adaptation by enhancing the
-dendrotoxin-sensitive potassium current. The effects of-opioid agonists on spike frequency adaptation were blocked by inhibiting
G-proteins with N-ethylmaleimide (NEM) and by blocking phospholipase A2. Application of arachidonic acid mimicked the actions of
DAMGO or morphine. These results show that -opioid receptor activation enhances spike frequency adaptation in lateral amygdala
neurons by modulating a voltage-dependent potassium channel containing Kv1.2 subunits, through activation of the phospholipase
A2–arachidonic acid–lipoxygenases cascade.
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Introduction
Opioid receptors are involved in a multitude of functions in the
CNS, including the regulation of stress, anxiety, and antinocicep-
tion (Vaccarino et al., 1999). There are three subtypes of opioid
receptors that can be distinguished by selective agonists and an-
tagonists: , , and . These receptors are found throughout the
CNS and PNS in distinct but overlapping distributions. The
amygdala, a structure that plays a critical role in emotional eval-
uation, in particular the response to fear and anxiety (LeDoux,
2000; Davis and Whalen, 2001), has one of the highest densities of
opioid binding sites in the CNS (Atweh and Kuhar, 1977). The
lateral nucleus of the amygdala is particularly enriched in
-opioid receptors (Paden et al., 1987). The opioid system in the
amygdala has been implicated in the modulation of fear (Good
and Westbrook, 1995), as well as consolidation of memories and
the antinociceptive actions of conditioned stimuli (McGaugh,
1989). In agreement with these modulatory effects, functional
imaging studies have shown that activation of  receptors is as-
sociated with inhibition of amygdala function (Liberzon et al.,
2002). However, the mechanisms underlying this inhibition are
not understood.
Opioid receptors are coupled to pertussis toxin-sensitive
G-proteins, and their cellular actions are generally mediated by
inhibition of adenyl cyclase, activation of inwardly rectifying po-
tassium conductances, or inhibition of voltage-dependent cal-
cium conductances (Law et al., 2000). Postsynaptically, opioid
receptor activation leads to membrane hyperpolarization,
whereas presynaptically opioids can inhibit transmitter release at
both excitatory and inhibitory synapses (Williams et al., 1982,
2001; Madison and Nicoll, 1988). In the lateral amygdala (LA),
activation of  receptors hyperpolarizes and reduces local
GABAergic inhibition in some pyramidal neurons (Sugita and
North, 1993). However, these effects would be expected to in-
crease excitation of lateral amygdala neurons.
In response to depolarizing stimuli, central neurons fire trains
of action potentials at frequencies that are controlled by activa-
tion of two slow calcium-dependent potassium currents, IAHP
and sIAHP (Sah, 1996). Of these, the IAHP current controls the
interspike interval during repetitive activity, whereas activation
of the sIAHP is responsible for spike frequency adaptation (Sah,
1996). The sIAHP current is the target for modulation by a wide
variety of neurotransmitters that downregulate the current and
thus decrease spike frequency adaptation (Madison and Nicoll,
1984; Nicoll, 1988). Because spike frequency adaptation plays a
key role in the transfer of integrated synaptic input to neuronal
output, modulation of sIAHP has important implications for the
operation of neuronal networks.
Projection neurons in the lateral amygdala are a heterogenous
population of cells that exhibit a range of firing properties with
varying degrees of spike frequency adaptation. These differences
are thought to result from varying levels of expression of the sIAHP
(Pare´ and Gaudreau, 1996; Faber et al., 2001; Faber and Sah, 2002).
We show here that these neurons express an -dendrotoxin (-
DTX)-sensitive, voltage-dependent potassium current that also
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plays a major role in spike frequency adaptation. This current is
selectively expressed in the apical dendrite rather than the soma.
Furthermore, it is upregulated by activation of -opioid receptors,
via a Gi/o-protein-mediated activation of the arachidonic acid path-
way, resulting in an enhancement in spike frequency adaptation.
Thus,  receptor activation greatly decreases the number of spikes
evoked by depolarizing stimuli, effectively inhibiting the output
from lateral amygdala pyramidal neurons. This effect of  receptor
activation may explain the inhibitory actions of opioids on amygdala
function.
Materials and Methods
Coronal rat brain slices (400 m) were obtained from Wistar rats (un-
sexed, 17- to 28-d-old) and maintained in artificial CSF (aCSF) contain-
ing the following (in mM): 118 NaCl, 2.5 KCl, 2.5 NaHCO3, 10 glucose,
2.5 MgCl2, 2.5 CaCl2, and 1.2 NaH2PO4. Procedures used to prepare the
slices were in accordance with the guidelines of the Australian National
University Animal Experimentation Ethics Committee. Whole-cell re-
cordings were made from neurons in the lateral amygdala in slices con-
tinuously perfused with oxygenated aCSF maintained at 28 –30°C using
infrared differential interference contrast techniques. Electrodes (3– 6
M) were filled with pipette solution containing the following (in mM):
135 KMeSO4, 8 NaCl, 10 HEPES, 2 Mg2ATP, and 0.3 Na3GTP, pH 7.3
with KOH (osmolarity, 290 mOsm/kg). Signals were recorded using a
patch-clamp amplifier (Axopatch 1-D or MultiClamp 700A; Axon In-
struments, Foster City, CA). Responses were filtered at 5 kHz and digi-
tized at 10 kHz (ITC-16; InstruTech, Greatneck, NY). All data were ac-
quired, stored, and analyzed on a Power Macintosh G4 (Apple
Computers, Cupertino, CA) using Axograph (Axon Instruments).
Only cells with a membrane potential more hyperpolarized than55
mV with overshooting action potentials were included in this study.
Access resistance was 5–30 M and was monitored throughout the ex-
periment. To investigate the firing properties of neurons, six to eight
current injection steps (600 msec) were applied from100 to600 pA
in 100 pA increments. Afterhyperpolarizations (AHPs) were evoked in
current clamp by a 100 msec, 400 pA current injection from a holding
potential of70 or50 mV. The ability of a cell to adapt was judged by
counting the number of spikes fired at threshold current injections, twice
threshold current injections (in which threshold was the current injec-
tion that first elicited an action potential), or in response to a 400 pA
current injection. Spike initiation threshold was measured at the begin-
ning of the upstroke of the action potential. To examine the effect of
opioids on transient responses, glutamate (200 M) was puffed onto the
cell soma using a Picospritzer II (General Valve, Fairfield, NJ) for 50 –100
msec in the presence of picrotoxin (100 M) and CGP55845A (1 M).
For whole-cell voltage-clamp experiments, recordings were restricted
to cells in which the series resistance was15 M and was compensated
by 60 – 80%. Potassium currents were isolated by inclusion of 1 M te-
trodotoxin (TTX) and 5 mM nickel (Ni) or 0.25– 0.4 mM cadmium
(Cd 2) to block Na and Ca 2 channels, respectively. To reduce the
amplitude of outward currents, the internal potassium concentration
was reduced to 90 mM by replacing KMeSO4 with NaCl and by the inclu-
sion of either 10 mM EGTA or 10 mM BAPTA to block activation of
calcium-dependent currents. Whole-cell current–voltage ( I–V) relation-
ships were investigated by giving 400 msec, 10 mV voltage steps from
20 to 90 mV from a holding potential of 60 or 50 mV. The I–V
plots derived from these were obtained by measuring the currents at
steady state at each potential. Capacitance and leak transients were sub-
tracted using a P/4 protocol. Nucleated somatic patches were obtained
once the whole-cell configuration had been established. To obtain these
patches, negative pressure was applied to the pipette, which was then
slowly withdrawn from the cell. As with the whole-cell recordings, so-
matic K currents were isolated by the inclusion of 10 mM EGTA or 10
mM BAPTA in the internal solution and by the external application of
0.25– 0.4 mM Cd 2 or 5 mM Ni. Sodium currents were not blocked.
Drugs were either bath applied or puffed onto nucleated somatic patches
as described above, using a micropipette filled with the drug solution,
and responses to a 400 msec, 60 mV step were measured every 10 sec.
Electrodes (10 –12 M) were used for dendritic recordings from rats
aged between 13 and 20 d. Having achieved a seal of at least 2 G, a
whole-cell configuration was obtained before slowly pulling the electrode
away from the cell and out of the slice to record from outside-out patches.
To generate activation plots, currents were converted to conductance
using a K reversal potential calculated using the Nernst equation.
Curves were then fitted with the following Boltzmann equation: G 
Gmax/(1  exp((V1/2  V )/k)), where Gmax is the maximum conduc-
tance, V1/2 is the half-maximal voltage, and k is the slope factor. The V1/2
and slope values were obtained by averaging the values obtained from
Boltzmann fits of individual experiments. Results are expressed as
mean  SEM. Student’s t tests were used for statistical comparisons
between groups.
TTX, -DTX, tityustoxin-K, and CGP55845 dendrotoxin-K
(DTX-K) were obtained from Alomone Labs (Jerusalem, Israel). EGTA,
BAPTA, cadmium, 4-aminopyridine (4-AP), nickel sulfate, noradrena-
line, N-ethylmaleimide (NEM), picrotoxin, and tetraethylammonium
(TEA) were obtained from Sigma (St. Louis, MO). D-Ala 2-N-Me-Phe 4-
Glycol 5-enkephalin (DAMGO) and naloxone were obtained from Tocris
Cookson (Ballwin, MO). Eicosatriyonic acid (ETI), arachidonyl triflu-
oromethyl ketone (AACOCF3), and arachidonic acid were obtained
from Cayman Chemical (Ann Arbor, MI).
Results
Whole-cell recordings were made from pyramidal neurons in the
lateral amygdala. These cells comprise the projection neurons
and form the principal cell type in this nucleus. In the majority of
these neurons, depolarizing current injection evokes a train of
action potentials that adapt fully after two to five spikes (Mahanty
and Sah, 1998; Faber et al., 2001) (Fig. 1a). Action potential trains
are followed by a slow AHP that lasts several seconds (Fig. 1g).
Application of noradrenaline markedly reduced spike frequency
adaptation (n 8) (Fig. 1a,b) by blocking the slow AHP (Fig. 1g).
Similar effects were also seen with acetylcholine, serotonin, and
glutamate (Faber and Sah, 2002). In contrast, activation of -
opioid receptors with morphine (1 M) or the specific agonist
DAMGO (0.5M) resulted in an enhancement of spike frequency
adaptation (Fig. 1c–f), which was reversible on washout of the
agonists. Morphine reduced the number of spikes evoked by a
prolonged current injection (600 msec, 400 pA) from 3.2 0.4 to
1.7 0.3 ( p 0.001; n 10). Similarly, application of DAMGO
reduced the number of spikes evoked from 4.6 0.7 to 2.4 0.6
( p  0.05; n  11). These actions of morphine and DAMGO
were fully blocked by the opioid antagonist naloxone (n  11;
data not shown). The effects of morphine and DAMGO were not
associated with a change in input resistance, resting membrane
potential, action potential initiation threshold, or enhancement
of the slow AHP (n  24) (Fig. 1h,i, Table 1). In fact, the slow
AHP was slightly attenuated in the presence of these agonists (Fig.
1h,i) because fewer spikes were initiated during the depolarizing
step used to evoke the AHP (data not shown). These results indi-
cate that two independent mechanisms contribute to spike fre-
quency adaptation in amygdala pyramidal neurons. One of these
is attributable to activation of the slow AHP, whereas the other is
attributable to activation of another current that is modulated by
-opioid receptors. In agreement with this finding, application
of DAMGO reversed the reduction in spike frequency adaptation
observed after blockade of the slow AHP by noradrenaline (n
4) (Fig. 1j).
Voltage-dependent potassium currents have been shown re-
cently to contribute to the discharge properties of central (Bek-
kersandDelaney,2001;Dodsonetal.,2002)andperipheral(Glaze-
brook et al., 2002) neurons. We therefore tested whether such
currents might also contribute to spike frequency adaptation in
lateral amygdala neurons. We initially tested the effects of the
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nonspecific potassium channel blocker 4-AP (Coetzee et al.,
1999). Application of 4-AP (30 –100 M) broadened the action
potential (Faber and Sah, 2002) and markedly reduced spike fre-
quency adaptation (Fig. 2a,d). With a 400 pA current injection,
4-AP increased the number of evoked action potentials from
5.0 0.6 to 10.6 1.0 ( p 0.001; n 36). At these concentra-
tions, 4-AP blocks potassium channels containing Kv1.1, Kv1.2,
Kv1.3, Kv1.5, Kv1.6, Kv3.1, and Kv3.2 subunits (Pongs, 1992;
Coetzee et al., 1999). To determine which of these subunits were
mediating the effects of 4-AP, we examined the actions of the
Table 1. Effects of potassium channel blockers and opioids on cell firing properties
Control -DTX Tityustoxin DTX-K Morphine DAMGO TEA
Membrane potential (mV) 63 1 59 1.3 58 1.5 61 1.1 62 1.8 63 1.6 66 1.8
Input resistance (M) 141 7 119 18 163 28 128 11 152 14 145 11 137 16
Spike half-width (msec) 1.1 0.04 1.1 0.05 1.0 0.03 1.1 0.03 0.9 0.1 1.1 0.03 2.1 0.1**
Spike initiation threshold (mV) 33 0.7 37 2.5 30 1.5 36 2.0 37 1.2 34 2.5 41 2**
Number of spikes fired 5.0 0.6 12.5 2* 9.7 3* 3 1.2 1.7 0.3** 2.4 0.6* 2.6 0.7**
AHP area (mV/sec) 5.3 0.8 3.8 1.1 5.6 3 3.8 1 4.8 3.1 3.9 1 6.6 2.2
n 49 8 3 3 10 11 14
*p 0.05; **p 0.005 versus control. Control values are the average of all of the cells.
Figure 1. -Opioid receptor activation increases spike frequency adaptation. a, Action po-
tentials evoked by a suprathreshold (200 pA) current injection rapidly adapt after three spikes.
Application of noradrenaline (10M) reduces spike frequency adaptation. b, Mean increase in
the number of action potentials for each current injection in control and in the presence of
noradrenaline (n 5). c, The number of action potentials evoked by a suprathreshold current
injection (400 pA) is markedly reduced by application of 1 M morphine. d, Mean number of
spikes evoked in control and in morphine for each current injection (n 10). e, DAMGO at 0.5
M also enhances spike frequency adaptation. f, Average data for 17 cells showing the reduc-
tion in spikes evoked by depolarizing current injections from 100 to 400 pA. g, The effect of
noradrenaline on spike frequency adaptation is mediated by blockade of the slow AHP. Mor-
phine ( h) and DAMGO ( i) do not enhance the slow AHP and, in fact, cause a small but insignif-
icant depression of the slow AHP. j, Application of DAMGO reverses the reduction in spike
frequency adaptation produced by noradrenaline. The inset shows that the slow calcium-
dependent AHP is blocked by noradrenaline and does not recover in the presence of DAMGO.
Figure 2. An -dendrotoxin-sensitive potassium current contributes to spike frequency
adaptation in addition to the slow AHP. a, Action potential train evoked by a 600 msec, 400 pA
current injection (left) shows marked spike frequency adaptation. Application of 100M 4-AP
greatly increases the number of evoked action potentials (middle trace) without depressing the
slow AHP (right). b, Effects of 4-AP on spike frequency are mimicked by-DTX. Right, As with
4-AP ( a),-DTX causes a small but insignificant enhancement of the slow AHP. c, The selective
Kv1.2 subunit blocker tityustoxin-K (100 nM) causes a similar depression of spike frequency
adaptation to-DTX (left) without significantly effecting the slow AHP (right). d, Average data
showing the increase in number of action potential-evoked depolarizing current injections in the
presence of 4-AP (n 19) or -DTX (n 24). e, Average data for the change in instantaneous
frequency with spike number showing the reduction in spike frequency adaptation by 4-AP (n19)
and -DTX (n 7). In control conditions, action potentials stop after six spikes, whereas in the
presence of 4-AP or-DTX, the cells continue to spike throughout the current injection.
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potassium channel blockers -DTX, DTX-K, tityustoxin-K,
and TEA.-DTX is a selective blocker of Kv1.1, Kv1.2, and Kv1.6
subunits (Pongs, 1992; Coetzee et al., 1999). As with 4-AP, appli-
cation of -DTX (100 –500 nM) significantly increased the num-
ber of spikes evoked by a 400 pA current injection from a mean of
5.7 0.9 to 12.5 2.0 ( p 0.05; n 8) (Fig. 2b). The reduction
in spike frequency adaptation can be seen as both an increase in
the number of action potentials evoked by a given current injec-
tion (Fig. 2d) and an increase in the frequency of action potential
discharge (Fig. 2e). In contrast, DTX-K (100 nM), a selective
blocker of channels containing Kv1.1 subunits (Wang et al.,
1999), had no effect on spike frequency adaptation (3.0 1.0 to
3.0  1.2; n  3; p  0.05) (Table 1). However, tityustoxin-K
(100 nM), a selective blocker of Kv1.2-containing potassium
channels (Werkman et al., 1993; Rogowski et al., 1994), blocked
spike frequency adaptation, increasing the number of spikes fired
from 3.0  0 to 9.7  2.9 (n  3; p  0.05) (Table 1), without
enhancing the slow AHP (Fig. 2c).
TEA (1 mM) also had no effect on the firing patterns of prin-
cipal lateral amygdala neurons (n 14; data not shown), with a
mean number of spikes fired at threshold of 1.14  0.1 in both
control and in the presence of TEA (n 14). With larger current
injections, fewer spikes were evoked in the presence of TEA as a
result of the marked spike broadening (Faber and Sah, 2002) and
a consequent increase in the AHP (data not shown). At this con-
centration, TEA has significant effects on K channels contain-
ing Kv1.1 and Kv1.6, whereas the IC50 for Kv1.2 subunits is100
mM (Gomez-Hernandez et al., 1997). The pooled data summa-
rizing the effects of morphine, DAMGO,-DTX, tityustoxin-K,
DTX-K, and TEA on lateral amygdala neurons is shown in Table
1. These results indicate that, in addition to the calcium-activated
sIAHP, activation of voltage-dependent potassium currents also
contributes to spike frequency adaptation in lateral amygdala
neurons. Our pharmacological results suggest that the channels
underlying this current likely contain Kv1.2 subunits (Pongs,
1992; Coetzee et al., 1999).
Potassium channels containing subunits sensitive to -DTX
and low concentrations of 4-AP are present in a number of cell
types and form currents that activate rapidly at depolarized po-
tentials and have slow inactivation kinetics (McCormick, 1991;
Foehring and Surmeier, 1993; Locke and Nerbonne, 1997; Bek-
kers and Delaney, 2001). We next tested for the presence of such
currents in lateral amygdala neurons. Under whole-cell voltage
clamp, depolarizing voltage steps from a holding potential of
50 mV evoked large outward currents that were substantially
reduced by application of -DTX (100 nM; p  0.001; n  11)
(Fig. 3a,b). The -DTX-sensitive current activated rapidly and
showed little inactivation over 450 msec. Activation plots of the
-DTX-sensitive current generated after converting to conduc-
tance (see Materials and Methods) were well fit by a Boltzmann
function, with a V1/2 of 5.2 4 mV and a slope of 12.8 1.3 mV
(n 11) (Fig. 3c). The subthreshold activation (action potential
threshold being 33  1 mV; n  49) and slow inactivation
kinetics of the -DTX-sensitive current make it ideally suited to
modulate spike frequency adaptation.
In cortical pyramidal neurons, an-DTX-sensitive potassium
current is concentrated on the soma and proximal apical den-
drites (Bekkers and Delaney, 2001). To examine the location of
the -DTX-sensitive current in lateral amygdala neurons, we
tested for the presence of this current in nucleated somatic
patches and outside-out patches excised from the apical dendrite.
In somatic patches, depolarization activated a fast inactivating
inward current, followed by an outward current (Fig. 4a– c). Co-
application of tetrodotoxin (1 M) and -DTX (100 nM) led to a
reversible blockade of the inward current, demonstrating that it
was a sodium current, but had no effect on the outward current in
five of five patches (Fig. 4a– c). The mean outward current re-
corded in response to a 60 mV voltage step from a holding po-
tential of60 mV was 176 40 pA in control and 177 40 pA
in the presence of-DTX ( p 0.05; n 5). In an additional two
somatic patches in which-DTX was applied alone, it also had no
effect (data not shown).
In contrast, application of-DTX (100 nM) to patches excised
from the apical dendrite (10 –100 m from the soma) reversibly
blocked the outward current in 11 of 19 patches to 40 10% of
control ( p  0.001; n  11) (Fig. 4d). The dendritic -DTX-
sensitive current activated at subthreshold membrane potentials,
similar to the whole-cell current, and showed little inactivation
(Fig. 4d). Activation plots generated after conversion to conduc-
tance gave a V1/2 of5.1 6 mV and a slope of 11.1 3 mV (Fig.
4c). These values are in good agreement with those measured for
whole-cell currents and are within the reported ranges for similar
currents in other cell types (McCormick, 1991; Foehring and
Surmeier, 1993; Locke and Nerbonne, 1997; Bekkers and
Delaney, 2001). These results demonstrate that the -DTX-
sensitive current in amygdala pyramidal neurons contributes to
spike frequency adaptation and is located in the proximal apical
dendrites but not on the soma.
Was the change in spike frequency adaptation by  receptor
activation attributable to modulation of the -DTX-sensitive
current? In whole-cell recordings, application of DAMGO con-
sistently increased the amplitude of the outward current. The
steady-state K current at 0 mV was enhanced by 32 11% ( p
0.05; n  9) (Fig. 5a) in the presence of DAMGO, an effect that
was fully blocked by the antagonist naloxone (n  4) (Fig. 5b).
The DAMGO-sensitive current activated at membrane potentials
positive to40 mV and had a V1/2 of8.6 3 mV and slope of
5.8 1 mV (n 6) (Fig. 5d). Furthermore, when applied in the
presence of -DTX, DAMGO had no effect on the outward cur-
Figure 3. An -DTX-sensitive current is present in LA pyramidal neurons. a, Whole-cell
voltage-clamp recording showing the outward current activated by voltage steps from70 to
40 mV in 10 mV increments from a holding potential of50 mV. Application of 100 nM
-DTX markedly reduced the outward current. The-DTX-sensitive current obtained by digital
subtraction is shown on the right. b, Average current–voltage relationship of the -DTX-
sensitive potassium current for 11 neurons. Currents have been normalized to the current mea-
sured at40 mV. c, The data from b has been converted to a conductance–voltage plot, and
the data points have been fit with a Boltzmann function (see Materials and Methods). A V1/2 of
5.24 mV and a slope of 12.81 mV (n11) for the-DTX-sensitive current were obtained
by averaging the Boltzmann fits of individual experiments.
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rent (n 4) (Fig. 5c). Consistent with its actions on the -DTX-
sensitive current, application of DAMGO in the presence of
-DTX (n 3) or 4-AP (n 5) had no effect on spike frequency
adaptation (Fig. 6). The mean number of spikes fired at threshold
in the presence of 4-AP or -DTX was 3.3 0.5 compared with
3.8  0.6 after application of DAMGO ( p  0.05; n  8). To-
gether, these results show that the actions of DAMGO on the
firing properties of these neurons result from enhancement of the
-DTX-sensitive outward current.
We next examined the mechanism through which -opioid
receptor activation enhances the -DTX-sensitive current to in-
crease spike frequency adaptation. Opioid receptors are coupled
to pertussis-sensitive G-proteins, and their actions have most
commonly been reported to result from either inhibition of ade-
nyl cyclase or activation of inwardly rectifying potassium chan-
nels. To confirm that the actions of opioids in LA neurons re-
sulted from activation of Gi/o receptors, we first tested the actions
of NEM, an alkylating agent that selectively uncouples pertussis-
Figure 4. The-DTX-sensitive current is located on the apical dendrite but not on the soma.
a– c, Nucleated patches excised from a pyramidal neuron. Currents were evoked by a 400 msec,
60 mV voltage step from a holding potential of60 mV every 10 sec. This voltage step evoked
a fast inward current, followed by a sustained outward current. After obtaining a stable base-
line, a combination of-DTX (100 nM) and TTX (1M) were applied by a puffer pipette (arrows).
a, The peak amplitudes of the inward current (open circles) and the sustained outward current
(filled circles) are plotted for two successive applications of the drugs. b, The mean SEM data
for the effect of-DTX on the outward current in seven patches. c, The patch currents evoked on
a slow time base are not blocked by-DTX. The arrows indicate the inward currents (which have
been truncated). The inset shows the inward currents evoked on a fast time base. d–f, Voltage-
dependent currents evoked by depolarizing voltage steps in an outside-out patch excised from
the apical dendrite. Traces on the left show currents under control conditions and after appli-
cation of-DTX. The-DTX-sensitive current obtained by digital subtraction is shown on the
right. The inset shows a time course of depression of the outward current evoked by a 60 mV
step by puffer application of-DTX to a dendritic patch. e, Current–voltage relationship of the
mean-DTX-sensitive current. Conductance–voltage plot averaged from six patches is shown
in f. The data points have been fit with a Boltzmann function (see Materials and Methods). A V1/2
of 5.1  6 mV and a slope of 11.1  3 mV (n  6) were obtained by averaging the
Boltzmann fits of individual experiments.
Figure 5. DAMGO enhances the -DTX-sensitive current through activation of -opioid
receptors. a, Whole-cell outward currents evoked by 10 mV depolarizing steps from a holding
potential of60 mV, before and after application of DAMGO (0.5 M). Note the increase in
amplitude of the sustained outward current. b, Application of DAMGO has no effect in the
presence of naloxone (1 M; traces on right). c, Application of DAMGO after blockade of the
-DTX-sensitive current with -DTX (100 nM) has no effect on the outward currents. d, A
Boltzmann fit of the DAMGO-sensitive current. A V1/2 of8.6 3 mV and a slope of 5.8 1
mV (n 6) were obtained by averaging the Boltzmann fits of individual experiments. e, Aver-
age data showing the potentiating effect of DAMGO on outward currents. DAMGO, n  9;
DAMGO plus naloxone, n 4, DAMGO plus-DTX, n 5. All values have been normalized to
the peak current recorded before application of DAMGO. *p 0.05.
Figure 6. The effects of DAMGO on spike frequency adaptation are blocked by-DTX and 4-AP.
Trains of action potentials evoked by 600 msec depolarizing current injections before and after the
application of either 100 nM-DTX ( a) or 100M 4-AP ( b). Application of DAMGO (0.5M) in the
presence of either-DTX or 4-AP has no effect on spike frequency adaptation (traces on right).
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sensitive G-proteins from receptors (Shapiro et al., 1994). Appli-
cation of NEM (50 M) completely blocked the actions of mor-
phine on the firing properties. The number of spikes evoked by a
400 pA current injection was 4.6 0.9 in control and 4.2 0.5 in
the presence of morphine and NEM (n 4; p 0.05) (Fig. 7a).
Consistent with -adrenergic receptor coupling to Gs (Stiles et
al., 1984), NEM (50 M) did not alter the effect of noradrenaline
(10 M) on the slow AHP or spike frequency adaptation (n 3;
data not shown).
-Opioid receptor activation has been shown to block trans-
mitter release via an -DTX-sensitive mechanism by activation
of an arachidonic acid-mediated pathway (Vaughan et al., 1997).
Therefore, we investigated whether the phospholipase A2
(PLA2)–arachidonic acid pathway is involved in the actions of
-opioids in the amygdala. We first tested the PLA2 inhibitor
AACOCF3 (28 M) (Balsinde et al., 1999). Application of
AACOCF3 blocked the actions of morphine, with 3.0 0.6 spikes
evoked in control and 3.3 0.9 in the presence of morphine and
AACOCF3 (n  3; p  0.05) (Fig. 7b). We then tested whether
application of arachidonic acid could mimic the actions of opi-
oids. Arachidonic acid (300 M) produced a marked enhance-
ment of spike frequency adaptation, reducing the number of
spikes evoked by a prolonged current injection (400 pA) from
2.5 0.3 spikes to 0.75 0.25 ( p 0.001; n 4) (Fig. 7d). This
effect was reversible on washout (n  3) (Fig. 7d). The effect of
arachidonic acid was precluded by previous perfusion with
-DTX, with the number of spikes evoked in the presence of
-DTX alone being 5.8  1.8 compared with 6.0  1.8 in the
presence of -DTX and arachidonic acid (n 4; p 0.05) (Fig.
7e). Furthermore, application of arachidonic acid enhanced the
whole-cell outward current evoked by a 100 mV step to40 mV
in a reversible manner by 14.7 2% ( p 0.001; n 4) (Fig. 7d),
similar to previous reports in CA1 pyramidal neurons (Colbert
and Pan, 1999). These findings show that the effect of -opioid-
mediated enhancement of spike frequency adaptation is medi-
ated by arachidonic acid. Finally, coapplication of morphine with
ETI (1M), a nonselective blocker of lipoxygenases, also blocked
the action of morphine on firing properties. In the presence of
these two agents, the number of spikes fired in response to a 400
pA current injection was 3.5  1.0 compared with 3.0  0.6 in
control (n 4; p 0.05) (Fig. 7f).
These results show that -opioids reduce the number of ac-
tion potentials evoked by prolonged current injections. To test
opioid receptor modulation during more physiological stimula-
tion, glutamate (200 M) was pressure applied to the soma of
lateral amygdala neurons in the presence of GABAergic blockers
(100 M picrotoxin and 1 M CGP55845A) to evoke suprath-
reshold potentials. Bath application of morphine (1 M) (Fig. 8)
reduced the number of spikes evoked by puffed glutamate appli-
cation from 3.2 0.5 to 1.4 0.4 (n 5; p 0.05) (Fig. 8a). This
effect was blocked by coapplication of naloxone (1 M) (control,
Figure 7. The enhancement of the-DTX-sensitive current by-opioids is mediated by a
pertussis toxin-sensitive G-protein and an arachidonic acid-mediated pathway. The enhance-
ment of spike frequency adaptation by morphine is blocked by coapplication with NEM ( a),
AACOCF3 ( b), and ETI ( c). d, Arachidonic acid (300M; AA) produces a marked enhancement of
spike frequency adaptation that is reversible on washout. e, Application of -DTX blocks the
effect of arachidonic acid on spike frequency adaptation (bottom traces). f, Arachidonic acid
(300 M) enhances the whole-cell outward current evoked by a 100 mV voltage step in a
reversible manner. g, Summary of the effect of agents acting on the arachidonic acid pathway
on the number of spikes evoked by a 400 pA, 600 msec current injection.
Figure 8. -Opioid activation enhances spike frequency adaptation of spikes evoked on
transient depolarizing potentials. Supramaximal responses were evoked by puffer application
of glutamate (200M; 50 –100 msec) onto the soma of lateral amygdala neurons in the pres-
ence of CGP55845A (1 M) and picrotoxin (100 M). a, Bath application of morphine (1 M)
reduces the number of spikes evoked on the depolarizing potentials. b, Coapplication of nalox-
one (1M) with morphine blocks the reduction in spike initiation. c, 4-AP (100M) increases
the number of spikes evoked and precludes the action of morphine on spike frequency adapta-
tion. d, Summary of the effects of morphine, naloxone, and 4-AP on the number of spikes
evoked by puffer glutamate application. *p 0.05. e, Schematic diagram showing the path-
way through which -opioid receptor activation enhances spike frequency adaptation. AA,
Arachidonic acid.
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3.8 1.1 spikes; morphine and naloxone, 3.5 1.1 spikes; n 4;
p  0.05) (Fig. 8b). In contrast, bath application of 4-AP (100
M) increased the number of spikes evoked from 2.3  0.3 to
4.3  0.3 (n  3; p  0.01) (Fig. 8c). As expected, subsequent
application of morphine (1 M) in addition to 4-AP failed to
reduce the number of spikes fired (4.3 0.3 spikes evoked in the
presence of 4-AP and morphine; n 3; p 0.05) (Fig. 8c).
Discussion
We have shown that pyramidal neurons in the lateral amygdala
express an -dendrotoxin-sensitive, voltage-dependent potas-
sium current that plays a major role in controlling spike fre-
quency adaptation. This current is not present on the soma but is
located on the apical dendritic tree. Activation of-opioid recep-
tors enhances the amplitude of the current by activation of an
arachidonic acid–lipoxygenase second-messenger pathway and
thus increases spike frequency adaptation. The effect of opioids in
activating inwardly rectifying potassium channels and inhibiting
voltage-dependent calcium channels are well known (Madison
and Nicoll, 1988; Williams et al., 1988, 2001; Law et al., 2000).
Our results demonstrate a new mechanism of opioid action in
reducing the repetitive discharge properties of projection neu-
rons in the lateral amygdala.
Spike frequency adaptation is thought to be primarily medi-
ated by activation of a slow calcium-activated potassium conduc-
tance, sIAHP (Sah, 1996). This current is a target of modulation for
a variety of neurotransmitters, virtually all of which reduce adap-
tation by blocking the sIAHP (Nicoll, 1988). We showed that a
voltage-dependent potassium current also plays a major role in
spike frequency adaptation and is upregulated by at least one class
of neurotransmitter. This potassium current is not present on the
soma but is selectively targeted to the apical dendrite and blocked
by low concentrations of 4-AP, -DTX, and tityustoxin-K, in-
dicating that the underlying channels contain Kv1.2 subunits.
Interestingly, the sIAHP current in hippocampal CA1 pyramidal
neurons, which is the main determinant of spike frequency ad-
aptation in these cells, has also been suggested to be located at
sites distant to the soma (Sah and Bekkers, 1996; Bekkers, 2000).
Thus, both currents that are involved in spike frequency adapta-
tion appear to be targeted to the dendritic tree. It would be inter-
esting to determine the location of the sIAHP current in amygdala
neurons.
The cellular actions of opioid receptor activation are mediated
by the Gi/o class of proteins that, in other cells, either inhibit
adenyl cyclase or activate inwardly rectifying potassium channels.
This leads to either hyperpolarization of neurons or inhibition of
transmitter release at a number of synapses (Law et al., 2000;
Williams et al., 2001). However,-opioid receptors are also cou-
pled to phospholipase A2 and lead to generation of arachidonic
acid (Fukuda et al., 1996). Three pathways have been described
for the metabolism of arachidonic acid: the lipooxygenase path-
way, the cyclooxgenase pathway, and the epoxygenase pathway,
the metabolites of which are known to modulate potassium chan-
nels (Piomelli and Greengard, 1990). We showed that -opioid
receptor activation in the lateral amygdala requires activation of
PLA2 via a pertussis toxin-sensitive G-protein. The subsequent
generation of arachidonic acid and activation of the lipoxygenase
system enhances the -DTX-sensitive potassium current (Fig.
8e). The V1/2 of the DAMGO-sensitive current is8.6 mV com-
pared with 5.2 mV for the -DTX-sensitive current. This is sig-
nificantly ( p  0.05) shifted to a more negative membrane po-
tentials, indicating that the increase in amplitude of the -DTX-
sensitive current results from a change in the voltage dependence
of this current.
In dissociated hippocampal neurons, -opioid receptor acti-
vation has been reported to potentiate a voltage-dependent po-
tassium current that activated near 60 mV and showed little
inactivation (Wimpey and Chavkin, 1991). However, the identity
of this current and its physiological role were not determined. A
slowly inactivating, voltage-dependent potassium current that is
blocked by low concentrations of 4-AP was initially identified in
hippocampal pyramidal neurons (Storm, 1988). This current was
named ID, because of its action in delaying action potential initi-
ation during long depolarizing current injections (Storm, 1988).
Subsequently, potassium currents with similar kinetics and sen-
sitivity to 4-AP but with variable biophysical properties have been
shown to also be blocked by -DTX in a number of different
neurons (Wu and Barish, 1992; Foehring and Surmeier, 1993;
Golding et al., 1999; Bekkers and Delaney, 2001). Our finding
that -opioid receptor activation potentiates the -DTX-
sensitive current indicates that the current shown to be upregu-
lated by  receptors in hippocampal neurons (Wimpey and
Chavkin, 1991) was likely to be an ID-like potassium current.
Inhibition of transmitter release by opioids has been shown to be
blocked by -DTX at a number of synapses (Zoltay and Cooper,
1993; Simmons and Chavkin, 1996; Vaughan et al., 1997; Lambe
and Aghajanian, 2001). Furthermore, the involvement of the ar-
achidonic cascade has been shown to be required in some of these
systems (Piomelli, 1994; Vaughan et al., 1997), suggesting that
opioid modulation of this current is likely to be widespread.
Unlike inwardly rectifying potassium currents, the -DTX-
sensitive potassium current is not active at resting membrane
potentials but requires depolarization for activation. Thus, the
physiological actions of upregulation of this current are evident
during brief depolarizations, such as during synaptic activation
or after somatic puffer application of glutamate. Activation of
this current may be the mechanism underlying the reduction in
amygdala activity that has been observed during aversive emo-
tional stimuli when  receptors in the amygdala are occupied
(Liberzon et al., 2002). The amygdala has long been implicated in
“emotional” processing and particularly in mediating responses
associated with fear and anxiety (LeDoux, 2000; Davis and
Whalen, 2001). An accumulating body of evidence indicates that
it also plays an important role in supraspinal mechanisms of
antinociception (Helmstetter, 1992; Tershner and Helmstetter,
2000). Given the involvement of the arachidonic acid–lipoxyge-
nase system in mediating these opioid actions in the amygdala, it
is tempting to suggest that nociceptive pathways may share a
common mechanism in different brain regions because this
mechanism is also used in the periaqueductal gray matter
(Christie et al., 2000). The amygdala has one of the highest con-
centrations of opioid receptors in the CNS, and activation of
opioid receptors in the basolateral complex has been implicated
in the role of the amygdala in the processing of fear (Good and
Westbrook, 1995), defensive behavior (Shaikh et al., 1991), and
nociception (Helmstetter et al., 1998; Kang et al., 1999; Manning
et al., 2001). Our results show that activation of receptors in the
lateral amygdala will greatly attenuate the output of these cells in
response to depolarizing stimuli. This mechanism may underlie
the antinociceptive and anxiolytic actions of opioid receptor ac-
tivation in the basolateral amygdala.
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